Catalyst Wire Dossier Catalyst Wire Dossier

ADZENYS XR-ODT

amphetamine
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ADZENYS XR-ODT, covering 2025-10-03 to 2025-10-03. Get the full timeline:

Most recent: Clinical Trial Update: ADZENYS XR-ODT™ in Children (4 to <6 Years) Diagnosed With Attention-deficit/Hyperactivity Disorder [Phase 4]

See pricing